Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results and Updates 2025 Outlook
MINNEAPOLIS, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter and year ended December 31, 2024.
CEO Tim Herbert told investors the company received a civil investigative demand from the Department of Justice in January ...
Inspire Medical shares dipped — but have since mostly recovered — following news of a government investigation following Q4 ...
Inspire Medical Systems said it is cooperating with U.S. Justice Department probe of allegations into allegations of false claims related to its Inspire system apnea implant. Shares fall 5.5% to $171 ...
Inspire Medical (INSP) disclosed that on January 17, it received a civil investigative demand from the Department of Justice U.S. Attorney’s ...
Inspire Medical Systems, Inc. announced preliminary fourth quarter and full year 2024 financial results, revealing anticipated revenues of approximately $239.5 million to $239.7 million for Q4 ...
Medical technology company Inspire Medical Systems (NYSE:INSP) will be reporting results tomorrow after market close. Here’s what you need to know. Inspire Medical Systems beat analysts ...
The promotion and reimbursement practices for the medtech company’s implantable CPAP alternative are under scrutiny.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback